[Skip to Navigation]
Sign In
Correction
August 17, 2020

Error in Figure

JAMA Neurol. 2020;77(11):1453. doi:10.1001/jamaneurol.2020.3037

In the Original Investigation titled “Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy,”1 published online July 7, 2020, there was an error in Figure 2. In the scale in panel A, red should indicate 1.5 and blue should indicate 1.0. This article was corrected online.

References
1.
Brendel  M, Barthel  H, van Eimeren  T,  et al.  Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy.   JAMA Neurol. Published online July 7, 2020. doi:10.1001/jamaneurol.2020.2526Google Scholar
×